Literature DB >> 20682240

Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.

Daniel Gotthardt1, Adolf Stiehl.   

Abstract

Primary sclerosing cholangitis is characterized by progressive fibrosing obliteration of the biliary tract. In some cases the disease is restricted to the small bile ducts, but most patients develop fibrotic stenoses of the larger bile ducts. Despite advances in magnetic resonance cholangiography, in unclear cases endoscopic retrograde cholangiography is necessary to make the correct diagnosis. In patients with total or subtotal strictures of the large bile ducts, these so-called dominant stenoses may be treated by endoscopic balloon dilatation and/or stent placement, though in the large majority of cases a stent placement is not necessary. Several studies showed an improvement of biochemical parameters after endoscopic treatment, and actuarial survival in these patients was improved compared with predicted survival. Endoscopic retrograde cholangiography allows tissue sampling, brush cytology, and bile analysis for early detection of cholangiocarcinoma, a major complication of primary sclerosing cholangitis. Despite successful endoscopic opening of bile duct stenoses, patients often progress to liver failure, leading to liver transplantation as the treatment of choice. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20682240     DOI: 10.1016/j.cld.2010.03.010

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  11 in total

1.  What is the current role of endoscopy in primary sclerosing cholangitis?

Authors:  Benjamin Tharian; Nayana Elizabeth George; Tony Chiew Keong Tham
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

2.  Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.

Authors:  Annika Gauss; Robert Ehehalt; Wolf-Dieter Lehmann; Gerhard Erben; Karl-Heinz Weiss; Yvonne Schaefer; Petra Kloeters-Plachky; Adolf Stiehl; Wolfgang Stremmel; Peter Sauer; Daniel Nils Gotthardt
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

3.  Advances in diagnosis and treatment of cholangiocarcinomas.

Authors:  Iliana Doycheva; Cynthia Levy
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-12

Review 4.  Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new?

Authors:  Rosa Ferreira; Rui Loureiro; Nuno Nunes; António Alberto Santos; Rui Maio; Marília Cravo; Maria Antónia Duarte
Journal:  World J Gastrointest Endosc       Date:  2016-02-25

5.  In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment.

Authors:  G Rudolph; D N Gotthardt; P Kloeters-Plachky; H Kulaksiz; P Schirmacher; A Stiehl
Journal:  Dig Dis Sci       Date:  2011-06-09       Impact factor: 3.199

Review 6.  Advanced therapeutic endoscopist and inflammatory bowel disease: dawn of a new role.

Authors:  Kunjam Modha; Udayakumar Navaneethan
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

7.  Magnetic resonance cholangiography compared with endoscopic retrograde cholangiography in the diagnosis of primary sclerosing cholangitis.

Authors:  Hossein Ahrar; Mohamad Saleh Jafarpishe; Ali Hekmatnia; Reza Solouki; Mohammad Hassan Emami
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

Review 8.  The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood.

Authors:  Priscila Menezes Ferri; Ana Cristina Simões E Silva; Soraya Luiza Campos Silva; Diego Junior Queiroga de Aquino; Eleonora Druve Tavares Fagundes; Débora Marques de Miranda; Alexandre Rodrigues Ferreira
Journal:  Gastroenterol Res Pract       Date:  2016-11-02       Impact factor: 2.260

9.  Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices.

Authors:  Moira B Hilscher; James H Tabibian; Elizabeth J Carey; Christopher J Gostout; Keith D Lindor
Journal:  Hepatol Commun       Date:  2018-05-04

10.  Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.

Authors:  Annika Gauss; Peter Sauer; Adolf Stiehl; Christian Rupp; Johannes Krisam; Yvonne Leopold; Petra Kloeters-Plachky; Wolfgang Stremmel; Daniel Gotthardt
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.